United States Antiandrogen Market Report 2016

Publisher Name :
Date: 19-Sep-2016
No. of pages: 119
Inquire Before Buying

Notes:

Sales, means the sales volume of Antiandrogen

Revenue, means the sales value of Antiandrogen

This report studies sales (consumption) of Antiandrogen in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- Pfizer Inc. (USA)

- Abbott Laboratories (USA)

- Genentech Inc. (USA)

- GlaxoSmithKline Plc (UK)

- Immunomedics, Inc. (USA)

- Indevus Pharmaceuticals Inc. (USA)

- Novartis AG (Switzerland)

- OSI Pharmaceuticals, Inc. (USA)

- Paladin Labs Inc. (Canada)

- ALZA Corporation (USA)

- Amgen Inc. (USA)

- AstraZeneca PLC (UK)

- Medimmune, LLC (USA)

- Bristol-Myers Squibb Company (USA)

- Cell Genesys Inc. (USA)

- Dendreon Corporation (USA)

- EUSA Pharma, (USA) Inc. (USA)

- F. Hoffmann-La Roche Ltd. (Switzerland)

- Progenics Pharmaceuticals, Inc. (USA)

- Sanofi-Aventis SA (France)

- Spectrum Pharmaceuticals, Inc. (USA)

- Takeda Pharmaceutical Company Limited (Japan)

Split by product Types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by applications, this report focuses on sales, market share and growth rate of Antiandrogen in each application, can be divided into

- Application 1

- Application 2

- Application 3

United States Antiandrogen Market Report 2016

Table of Contents
United States Antiandrogen Market Report 2016
1 Antiandrogen Overview
1.1 Product Overview and Scope of Antiandrogen
1.2 Classification of Antiandrogen
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Antiandrogen
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 USA Market Size Sales (Value) and Revenue (Volume) of Antiandrogen (2011-2021)
1.4.1 USA Antiandrogen Sales and Growth Rate (2011-2021)
1.4.2 USA Antiandrogen Revenue and Growth Rate (2011-2021)
2 USA Antiandrogen Competition by Manufacturers
2.1 USA Antiandrogen Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 USA Antiandrogen Revenue and Share by Manufactures (2015 and 2016)
2.3 USA Antiandrogen Average Price by Manufactures (2015 and 2016)
2.4 Antiandrogen Market Competitive Situation and Trends
2.4.1 Antiandrogen Market Concentration Rate
2.4.2 Antiandrogen Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 USA Antiandrogen Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 USA Antiandrogen Sales and Market Share by Type (2011-2016)
3.2 USA Antiandrogen Revenue and Market Share by Type (2011-2016)
3.3 USA Antiandrogen Price by Type (2011-2016)
3.4 USA Antiandrogen Sales Growth Rate by Type (2011-2016)
4 USA Antiandrogen Sales (Volume) by Application (2011-2016)
4.1 USA Antiandrogen Sales and Market Share by Application (2011-2016)
4.2 USA Antiandrogen Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 USA Antiandrogen Manufacturers Profiles/Analysis
5.1 Pfizer Inc. (USA)
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Antiandrogen Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Pfizer Inc. (USA) Antiandrogen Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Abbott Laboratories (USA)
5.2.2 Antiandrogen Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Abbott Laboratories (USA) Antiandrogen Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 Genentech Inc. (USA)
5.3.2 Antiandrogen Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 Genentech Inc. (USA) Antiandrogen Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 GlaxoSmithKline Plc (UK)
5.4.2 Antiandrogen Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 GlaxoSmithKline Plc (UK) Antiandrogen Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Immunomedics, Inc. (USA)
5.5.2 Antiandrogen Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Immunomedics, Inc. (USA) Antiandrogen Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Indevus Pharmaceuticals Inc. (USA)
5.6.2 Antiandrogen Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Indevus Pharmaceuticals Inc. (USA) Antiandrogen Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Novartis AG (Switzerland)
5.7.2 Antiandrogen Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Novartis AG (Switzerland) Antiandrogen Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 OSI Pharmaceuticals, Inc. (USA)
5.8.2 Antiandrogen Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 OSI Pharmaceuticals, Inc. (USA) Antiandrogen Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 Paladin Labs Inc. (Canada)
5.9.2 Antiandrogen Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 Paladin Labs Inc. (Canada) Antiandrogen Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 ALZA Corporation (USA)
5.10.2 Antiandrogen Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 ALZA Corporation (USA) Antiandrogen Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
5.11 Amgen Inc. (USA)
5.12 AstraZeneca PLC (UK)
5.13 Medimmune, LLC (USA)
5.14 Bristol-Myers Squibb Company (USA)
5.15 Cell Genesys Inc. (USA)
5.16 Dendreon Corporation (USA)
5.17 EUSA Pharma, (USA) Inc. (USA)
5.18 F. Hoffmann-La Roche Ltd. (Switzerland)
5.19 Progenics Pharmaceuticals, Inc. (USA)
5.20 Sanofi-Aventis SA (France)
5.21 Spectrum Pharmaceuticals, Inc. (USA)
5.22 Takeda Pharmaceutical Company Limited (Japan)
6 Antiandrogen Manufacturing Cost Analysis
6.1 Antiandrogen Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Antiandrogen
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Antiandrogen Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Antiandrogen Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 USA Antiandrogen Market Forecast (2016-2021)
10.1 USA Antiandrogen Sales, Revenue Forecast (2016-2021)
10.2 USA Antiandrogen Sales Forecast by Type (2016-2021)
10.3 USA Antiandrogen Sales Forecast by Application (2016-2021)
10.4 Antiandrogen Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Antiandrogen
Table Classification of Antiandrogen
Figure USA Sales Market Share of Antiandrogen by Type in 2015
Table Application of Antiandrogen
Figure USA Sales Market Share of Antiandrogen by Application in 2015
Figure USA Antiandrogen Sales and Growth Rate (2011-2021)
Figure USA Antiandrogen Revenue and Growth Rate (2011-2021)
Table USA Antiandrogen Sales of Key Manufacturers (2015 and 2016)
Table USA Antiandrogen Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Antiandrogen Sales Share by Manufacturers
Figure 2016 Antiandrogen Sales Share by Manufacturers
Table USA Antiandrogen Revenue by Manufacturers (2015 and 2016)
Table USA Antiandrogen Revenue Share by Manufacturers (2015 and 2016)
Table 2015 USA Antiandrogen Revenue Share by Manufacturers
Table 2016 USA Antiandrogen Revenue Share by Manufacturers
Table USA Market Antiandrogen Average Price of Key Manufacturers (2015 and 2016)
Figure USA Market Antiandrogen Average Price of Key Manufacturers in 2015
Figure Antiandrogen Market Share of Top 3 Manufacturers
Figure Antiandrogen Market Share of Top 5 Manufacturers
Table USA Antiandrogen Sales by Type (2011-2016)
Table USA Antiandrogen Sales Share by Type (2011-2016)
Figure USA Antiandrogen Sales Market Share by Type in 2015
Table USA Antiandrogen Revenue and Market Share by Type (2011-2016)
Table USA Antiandrogen Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Antiandrogen by Type (2011-2016)
Table USA Antiandrogen Price by Type (2011-2016)
Figure USA Antiandrogen Sales Growth Rate by Type (2011-2016)
Table USA Antiandrogen Sales by Application (2011-2016)
Table USA Antiandrogen Sales Market Share by Application (2011-2016)
Figure USA Antiandrogen Sales Market Share by Application in 2015
Table USA Antiandrogen Sales Growth Rate by Application (2011-2016)
Figure USA Antiandrogen Sales Growth Rate by Application (2011-2016)
Table Pfizer Inc. (USA) Basic Information List
Table Pfizer Inc. (USA) Antiandrogen Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Inc. (USA) Antiandrogen Sales Market Share (2011-2016)
Table Abbott Laboratories (USA) Basic Information List
Table Abbott Laboratories (USA) Antiandrogen Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abbott Laboratories (USA) Antiandrogen Sales Market Share (2011-2016)
Table Genentech Inc. (USA) Basic Information List
Table Genentech Inc. (USA) Antiandrogen Sales, Revenue, Price and Gross Margin (2011-2016)
Table Genentech Inc. (USA) Antiandrogen Sales Market Share (2011-2016)
Table GlaxoSmithKline Plc (UK) Basic Information List
Table GlaxoSmithKline Plc (UK) Antiandrogen Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Plc (UK) Antiandrogen Sales Market Share (2011-2016)
Table Immunomedics, Inc. (USA) Basic Information List
Table Immunomedics, Inc. (USA) Antiandrogen Sales, Revenue, Price and Gross Margin (2011-2016)
Table Immunomedics, Inc. (USA) Antiandrogen Sales Market Share (2011-2016)
Table Indevus Pharmaceuticals Inc. (USA) Basic Information List
Table Indevus Pharmaceuticals Inc. (USA) Antiandrogen Sales, Revenue, Price and Gross Margin (2011-2016)
Table Indevus Pharmaceuticals Inc. (USA) Antiandrogen Sales Market Share (2011-2016)
Table Novartis AG (Switzerland) Basic Information List
Table Novartis AG (Switzerland) Antiandrogen Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis AG (Switzerland) Antiandrogen Sales Market Share (2011-2016)
Table OSI Pharmaceuticals, Inc. (USA) Basic Information List
Table OSI Pharmaceuticals, Inc. (USA) Antiandrogen Sales, Revenue, Price and Gross Margin (2011-2016)
Table OSI Pharmaceuticals, Inc. (USA) Antiandrogen Sales Market Share (2011-2016)
Table Paladin Labs Inc. (Canada) Basic Information List
Table Paladin Labs Inc. (Canada) Antiandrogen Sales, Revenue, Price and Gross Margin (2011-2016)
Table Paladin Labs Inc. (Canada) Antiandrogen Sales Market Share (2011-2016)
Table ALZA Corporation (USA) Basic Information List
Table ALZA Corporation (USA) Antiandrogen Sales, Revenue, Price and Gross Margin (2011-2016)
Table ALZA Corporation (USA) Antiandrogen Sales Market Share (2011-2016)
Table Amgen Inc. (USA) Basic Information List
Table Amgen Inc. (USA) Antiandrogen Sales, Revenue, Price and Gross Margin (2011-2016)
Table Amgen Inc. (USA) Antiandrogen Sales Market Share (2011-2016)
Table AstraZeneca PLC (UK) Basic Information List
Table AstraZeneca PLC (UK) Antiandrogen Sales, Revenue, Price and Gross Margin (2011-2016)
Table AstraZeneca PLC (UK) Antiandrogen Sales Market Share (2011-2016)
Table Medimmune, LLC (USA) Basic Information List
Table Medimmune, LLC (USA) Antiandrogen Sales, Revenue, Price and Gross Margin (2011-2016)
Table Medimmune, LLC (USA) Antiandrogen Sales Market Share (2011-2016)
Table Bristol-Myers Squibb Company (USA) Basic Information List
Table Bristol-Myers Squibb Company (USA) Antiandrogen Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol-Myers Squibb Company (USA) Antiandrogen Sales Market Share (2011-2016)
Table Cell Genesys Inc. (USA) Basic Information List
Table Cell Genesys Inc. (USA) Antiandrogen Sales, Revenue, Price and Gross Margin (2011-2016)
Table Cell Genesys Inc. (USA) Antiandrogen Sales Market Share (2011-2016)
Table Dendreon Corporation (USA) Basic Information List
Table Dendreon Corporation (USA) Antiandrogen Sales, Revenue, Price and Gross Margin (2011-2016)
Table Dendreon Corporation (USA) Antiandrogen Sales Market Share (2011-2016)
Table EUSA Pharma, (USA) Inc. (USA) Basic Information List
Table EUSA Pharma, (USA) Inc. (USA) Antiandrogen Sales, Revenue, Price and Gross Margin (2011-2016)
Table EUSA Pharma, (USA) Inc. (USA) Antiandrogen Sales Market Share (2011-2016)
Table F. Hoffmann-La Roche Ltd. (Switzerland) Basic Information List
Table F. Hoffmann-La Roche Ltd. (Switzerland) Antiandrogen Sales, Revenue, Price and Gross Margin (2011-2016)
Table F. Hoffmann-La Roche Ltd. (Switzerland) Antiandrogen Sales Market Share (2011-2016)
Table Progenics Pharmaceuticals, Inc. (USA) Basic Information List
Table Progenics Pharmaceuticals, Inc. (USA) Antiandrogen Sales, Revenue, Price and Gross Margin (2011-2016)
Table Progenics Pharmaceuticals, Inc. (USA) Antiandrogen Sales Market Share (2011-2016)
Table Sanofi-Aventis SA (France) Basic Information List
Table Sanofi-Aventis SA (France) Antiandrogen Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi-Aventis SA (France) Antiandrogen Sales Market Share (2011-2016)
Table Spectrum Pharmaceuticals, Inc. (USA) Basic Information List
Table Spectrum Pharmaceuticals, Inc. (USA) Antiandrogen Sales, Revenue, Price and Gross Margin (2011-2016)
Table Spectrum Pharmaceuticals, Inc. (USA) Antiandrogen Sales Market Share (2011-2016)
Table Takeda Pharmaceutical Company Limited (Japan) Basic Information List
Table Takeda Pharmaceutical Company Limited (Japan) Antiandrogen Sales, Revenue, Price and Gross Margin (2011-2016)
Table Takeda Pharmaceutical Company Limited (Japan) Antiandrogen Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antiandrogen
Figure Manufacturing Process Analysis of Antiandrogen
Figure Antiandrogen Industrial Chain Analysis
Table Raw Materials Sources of Antiandrogen Major Manufacturers in 2015
Table Major Buyers of Antiandrogen
Table Distributors/Traders List
Figure USA Antiandrogen Production and Growth Rate Forecast (2016-2021)
Figure USA Antiandrogen Revenue and Growth Rate Forecast (2016-2021)
Table USA Antiandrogen Production Forecast by Type (2016-2021)
Table USA Antiandrogen Consumption Forecast by Application (2016-2021)
  • C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 3500 Onwards        Pages: 72
    C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) - Pipeline Review, H2 2017 Summary C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) pipeline Target constitutes close to 15 molecules. Out of which approximately 12 molecules are developed by companies and remaining by the universities/institutes. The latest report C-C Chemokine Receptor Type 5 - Pipeline Review, H2 2017, outlays comprehensive info......
  • C-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High Affinity Interleukin 8 Receptor B or IL8 Receptor Type 2 or CD182 or CXCR2) - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 3500 Onwards        Pages: 59
    C-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High Affinity Interleukin 8 Receptor B or IL8 Receptor Type 2 or CD182 or CXCR2) - Pipeline Review, H2 2017 Summary C-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High Affinity Interleukin 8 Receptor B or IL8 Receptor Type 2 or CD182 or CXCR2) - CXCR2 or Interleukin 8 receptor, beta is a chemokine receptor. It binds to IL8 with high affinity, and transduces the signal through a G-prot......
  • C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 3500 Onwards        Pages: 54
    C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) - Pipeline Review, H2 2017 Summary C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) pipeline Target constitutes close to 7 molecules. Out of which approximately 6 molecules are developed by companies and remaining by the universities/institutes. The latest report C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) - Pipeline Review, H2 2017, outlays comprehensive information on the C5a Anaphylato......
  • Prostaglandin D2 Receptor 2 (Chemoattractant Receptor Homologous Molecule Expressed On Th2 Cells or G Protein Coupled Receptor 44 or GPR44 or CD294 or PTGDR2) - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 3500 Onwards        Pages: 53
    Prostaglandin D2 Receptor 2 (Chemoattractant Receptor Homologous Molecule Expressed On Th2 Cells or G Protein Coupled Receptor 44 or GPR44 or CD294 or PTGDR2) - Pipeline Review, H2 2017 Summary Prostaglandin D2 Receptor 2 (Chemoattractant Receptor Homologous Molecule Expressed On Th2 Cells or G Protein Coupled Receptor 44 or GPR44 or CD294 or PTGDR2) - Prostaglandin D2 (PGD2) receptors are G protein-coupled receptors that binds and is activated by prostaglandin D2. ......
  • Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 3500 Onwards        Pages: 45
    Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) - Pipeline Review, H2 2017 Summary According to the recently published report 'Prostaglandin E2 Receptor EP4 Subtype - Pipeline Review, H2 2017'; Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) pipeline Target constitutes close to 11 molecules. Out of which approximately 10 molecules are developed by companies and remaining by the universities/institutes. ......
  • Sphingosine 1-Phosphate Receptor 1 (Endothelial Differentiation G Protein Coupled Receptor 1 or Sphingosine 1 Phosphate Receptor Edg 1 or CD363 or S1PR1) - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 3500 Onwards        Pages: 74
    Sphingosine 1-Phosphate Receptor 1 (Endothelial Differentiation G Protein Coupled Receptor 1 or Sphingosine 1 Phosphate Receptor Edg 1 or CD363 or S1PR1) - Pipeline Review, H2 2017 Summary Sphingosine 1-Phosphate Receptor 1 (Endothelial Differentiation G Protein Coupled Receptor 1 or Sphingosine 1 Phosphate Receptor Edg 1 or CD363 or S1PR1) pipeline Target constitutes close to 17 molecules. Out of which approximately 17 molecules are developed by Companies. The lat......
  • Glucagon Like Peptide 2 Receptor (GLP2R) - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 3500 Onwards        Pages: 49
    Glucagon Like Peptide 2 Receptor (GLP2R) - Pipeline Review, H2 2017 Summary Glucagon Like Peptide 2 Receptor (GLP2R) - Glucagon-like peptide 2 receptor (GLP-2R) is a protein encoded by the GLP2R gene. GLP2R, a G protein-coupled receptor superfamily member is expressed in the gut. GLP2 stimulates intestinal growth and up regulates villus height in the small intestine, concomitant with increased crypt cell proliferation and decreased enterocyte apoptosis. GLP2 prevent......
  • Metabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 3500 Onwards        Pages: 55
    Metabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) - Pipeline Review, H2 2017 Summary According to the recently published report 'Metabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) - Pipeline Review, H2 2017'; Metabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) pipeline Target constitutes close to 14 molecules. Out of which approximately 13 molecules are developed by companies and remaining by the universities/institutes. M......
  • Restenosis - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 2000 Onwards        Pages: 48
    Restenosis - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Restenosis - Pipeline Review, H2 2017, provides an overview of the Restenosis (Cardiovascular) pipeline landscape. Restenosis is re-narrowing of a blood vessel which leads to restricted blood flow. Symptoms include shortness of breath, difficulty walking and chest pain. Risk factors include increasing age, gender, family hist......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs